JC Medical, Inc.

JC Medical, Inc. is a privately held medical device company founded in 2007 by Zhang Ji. The company specializes in the development and commercialization of the J-Valve® System, a transcatheter aortic valve replacement (TAVR) technology aimed at treating severe aortic regurgitation. This minimally invasive system offers an alternative to traditional open-heart surgery, utilizing a transfemoral delivery approach for valve implantation. The J-Valve System has undergone clinical trials in the U.S. and China to ensure its safety and efficacy. In August 2023, it received FDA Breakthrough Device designation, underscoring its potential to meet significant medical needs in cardiovascular care. JC Medical primarily serves hospitals, cardiovascular surgeons, and healthcare providers focused on cardiac treatment, with a market presence in the United States and Greater China. In August 2024, the company was acquired by Edwards Lifesciences, which now holds the rights to the J-Valve system outside Greater China.

• Employees 13